OBJECTIVE -The aim of this study was to determine the prevalence of diabetes and impaired fasting glucose (IFG) and their association with cardiovascular risk factors and to evaluate the management of blood glucose, blood pressure, and cholesterol in individuals with diabetes by geographical regions of Thailand.
D
iabetes and its associated complications are a major health and economic burden worldwide (1, 2) , and the burden is expected to continue to increase (3) . This problem is particularly relevant to the Asia-Pacific region, where lifestyle changes associated with rapid economic development, improved survival from communicable diseases, and genetic susceptibility have led to rising diabetes prevalence (4, 5) .
Thailand provides a prime example of this trend (6) . A survey in 1999 estimated that 9.6% of Thai adults aged Ն35 years had diabetes with 5.4% having impaired fasting glucose (IFG) (fasting plasma glucose [FPG] Ն6.1 mmol/l and Ͻ7.0 mmol/l) (7) . In half of those with diabetes, the disease had not been previously diagnosed, whereas of those with diagnosed diabetes, 18% were not receiving oral antiglycemic agents. Among those with diagnosed diabetes and concomitant hypertension, one-third were not receiving blood pressure-lowering medication. These individuals represent lost opportunities for reducing the risks of the macroand microvascular diseases associated with diabetes.
To monitor the effectiveness of the health system response, routine measurement of the prevalence and management of diabetes is crucial. In Thailand, subnational monitoring is also essential, given health administration decentralization, as well as differences in economic development and lifestyle between geographical regions (8) . In this article, we describe the prevalence of diabetes and IFG as well as the diagnosis, treatment, and control of blood glucose, blood pressure, and cholesterol in those with diabetes in five geographic regions of Thailand. We used data from the 2004 Third National Health Examination Survey (NHESIII) of Ͼ37,000 fasting individuals aged Ն15 years, which, to date, is the single largest survey of FPG in an adult population. 
RESEARCH DESIGN AND METHODS

Data collection and measurement
Demographic characteristics, previous diagnosis of diabetes, high blood pressure, or high cholesterol and corresponding medication use, and smoking habits were determined on the basis of an interview. Three serial measurements of blood pressure, 1 min apart, were made using a mercury sphygmomanometer. Weight, height, and waist circumference were directly measured using standard techniques (9) . Participants were asked to fast for 12 h overnight before the venous blood sample was obtained. Sera were frozen and transferred to a regional university laboratory for analysis of plasma glucose using a hexokinase enzyme method. Serum total cholesterol was measured using enzymatic methods. All regional laboratories were standardized by a central laboratory at the Ministry of Public Health.
Definition
Diabetes was defined as FPG Ն7.0 mmol/l, use of medication (oral antiglycemic agents or insulin) for the treatment of diabetes during the previous 2 weeks, or a report of a previous diagnosis of diabetes by a medical doctor. Diagnosed diabetes was defined as meeting the criteria for diabetes and having a previous diagnosis of diabetes by a medical doctor. As A1C measurements were not obtained in the survey, control of plasma glucose was defined as FPG Ͻ7.8 mmol/l (10). IFG was defined as FPG Ն5.6 and Ͻ7.0 mmol/l. High blood pressure was defined as systolic blood pressure Ն130 mmHg or diastolic blood pressure Ն80 mmHg (average of the two measurements with the lowest variability) or use of blood pressure-lowering medication during the previous 2 weeks (11). High cholesterol was defined as total serum cholesterol Ն6.2 mmol/l or cholesterol-lowering drug use during the previous 2 weeks. Central obesity was defined as a waist circumference of Ն90 cm in men and Ն80 cm in women (12) . Overweight was defined as BMI of Ն25 kg/m 2 (12,13). 
Diabetes prevalence and management in Thailand
Statistical methods The analysis was restricted to respondents who had fasted over the previous 12 h before blood collection (94.5% of respondents) with the sample weighted against the registered 2004 population by public health administration area, area of residence (urban/rural or geographical zone for Bangkok), sex, and 5-year age-groups up to 80ϩ years. All comparisons by sex, area of residence, geographic region, and fasting plasma glucose status were ageand sex-standardized to the national population. Adjusted Wald tests were used to determine statistical significance with P Ͻ 0.05 considered statistically significant. Robust methods of variance estimation were used to take into account the complex survey design using Stata 9.2 (StataCorp, College Station, TX). , and 53.5% (48.3-58.6%) having central obesity (waist circumference Ն90 cm in men and Ն80 cm in women). Those with diagnosed diabetes tended to have a higher prevalence of high blood pressure, high cholesterol, and overweight but a lower prevalence of smoking than those in whom diabetes had not been previously diagnosed (Table  2 ). Individuals with IFG had more concomitant cardiovascular risk factors, except for smoking, than those with normal FPG (Table 2) .
RESULTS
Diagnosis of diabetes and treatment and control of blood glucose, blood pressure, and cholesterol in individuals with diabetes Of those identified as having diabetes in the survey, 53.3% (95% CI 47.8 -58.8%) had not previously had the diagnosis of diabetes. Nondiagnosis was higher in men (62.6%) than in women (62.6 vs. 46.2%, respectively; P Ͻ 0.001 for the age-standardized comparison). This equates to an estimated 1.6 million (0.8 million men and 0.8 million women) Thais aged Ն15 years with undiagnosed diabetes. Although diagnosis rates increased with age, 48.1% of men and 36.7% of women aged Ն55 years had diabetes that remained undiagnosed. Of those in whom diabetes was previously diagnosed, 90.7% (95% CI 87.7-92.9%) were receiving either oral antiglycemic agents or insulin, and of those receiving treatment, 41.6% (37.8 -45.5%) had FPG controlled to Ͻ7.8 mmol/l. Glycemic control was higher in women than in men (44.6 vs. 35.8%; P Ͻ 0.01). Of those in whom diabetes had been diagnosed, 71.1% had received advice from health personnel to reduce their weight, 90.3% to increase their physical activity levels, and 92.5% to consume a healthier diet. Diagnosis rates tended to be higher in urban than in rural men, but the difference was not significant (42.2 vs. 34.6% diagnosed, respectively; P ϭ 0.057). Rates of diagnosis were similar for urban and rural females (55.0 vs. 52.7%). Rates of glycemic control were higher in rural than in urban women receiving treatment (47.3 vs. 38.3%; P Ͻ 0.05). Both Bangkok and the South had higher rates of diagnosis than the Central and Northeast regions (Fig. 2) (P Ͻ 0.01 for both compared with Bangkok; P Ͻ 0.05 compared with the South). The fraction of treated individuals achieving glycemic control was lower in Bangkok than in the Central and North regions (P Ͻ 0.01 for both comparisons) and higher in the North compared with the South and Northeast (P Ͻ 0.05 for both).
Of those individuals with diabetes and concomitant high blood pressure, 65.9% were not previously aware that they had high blood pressure. Of those who were aware, 82.2% were taking blood pressure-lowering medication, and of those taking medication, 14.9% had blood pressure controlled to Ͻ130/80 mmHg. Rates of awareness were lower in rural than in urban areas for both men (26.3 vs. 37.0%; P Ͻ 0.01) and women (34.9 vs. 43.5%; P Ͻ 0.05). The Northeast region had the lowest rates of awareness (Fig. 2) (P Ͻ 0.01 for all comparisons), whereas Bangkok had the highest (P Ͻ 0.05 for all comparisons). The fraction of those receiving blood pressure-lowering medication who had blood pressure Ͻ130/80 mmHg was universally low but higher in Bangkok than in other regions (Fig. 2) (P Ͻ 0.01 for all comparisons).
Diagnosis, treatment, and control levels of high cholesterol were low. Of individuals with diabetes and high cholesterol, high cholesterol had not been previously diagnosed in 72.0%. Of those in whom it had been diagnosed, 80.7% were receiving cholesterollowering medication, and of those receiving medication, 63.1% had total cholesterol controlled to Ͻ6.2 mmol/l. Rates of diagnosis were lower in rural than in urban women (21.0 vs. 36.3%; P Ͻ 0.001) but similar in rural and urban men (30.2 vs. 32.2%). The Northeast had the lowest rates of diagnosis ( CONCLUSIONS -This study demonstrates a continued high prevalence of diabetes and IFG in Thailand consistent with a previous survey (7) . These rates are similar to those in the U.S. (14) and higher than those of China (15) . A higher prevalence of diabetes was found in middle to older aged women compared with men of the same age, whereas the prevalence of IFG was higher among younger to middle aged men compared with women of the same age. This pattern is similar to that of a recent Korean survey (16) . Urban men were more likely to have diabetes than rural men, whereas the prevalence of diabetes was similar in rural and urban women. This finding may be related to the shift in obesity from high to low socioeconomic groups occurring earlier in women, as has been noted in other populations (17) . Despite these differentials, diabetes prevalence is relatively uniform throughout Thailand.
In two-thirds of individuals with diabetes in the current survey (1.6 million individuals), the disease had not been previously diagnosed. Subsequently, -standardized cardiovascular risk factors among those with normal fasting plasma glucose, IFG, and undiagnosed and there were low rates of treatment and control of plasma glucose with insulin or oral antiglycemic agents. Of further concern are the high levels of cardiovascular risk factors, such as high blood pressure and high cholesterol in those with diabetes. Diagnosis, treatment, and control rates of these risk factors among those with diabetes are also low. As diabetes itself is an independent risk factor for coronary heart disease, stroke, and renal disease (2,18), control of cholesterol and blood pressure is essential to reduce the risk of these events. The economic burden associated with these outcomes is highlighted by the potentially large financial burden of including renal dialysis on the Thai universal health insurance scheme (19) . A crucial finding is that a large proportion of older individuals have undiagnosed diabetes, and these individuals have the greatest risk of macro-and microvascular diseases. When these findings are combined with the presence of an aging population and the 5.7 million individuals with IFG, it is clear that a scaled-up response is needed to better diagnose and treat diabetes and prevent progression to diabetes in those with IFG (20) if the health and economic burden of the condition is to be reduced. Recognizing the growing burden of diabetes and other noncommunicable diseases and risk factors, the Ministry of Public Health launched a nationwide program, "Healthy Thailand," in 2004. This program includes components promoting healthier lifestyles (physical activity and diet) and set a target for 60% of Thai people aged Ն40 years to be screened for IFG and diabetes by the end of 2006. Surveys must continue to be routinely conducted to monitor the impact of these programs. Furthermore, the need for subnational assessment is highlighted by the lower rates of diagnosis for diabetes and associated risk factors in the Northeast and in rural compared with urban populations. The distribution of health resources, such as medical doctors, has historically been biased against both these populations (21).
Several limitations should be considered. Although replacements were made based on age, sex, and cluster, information to determine the response rate before replacement was not available. Differentials in the final collection rate may also obscure variation across geographic regions. Oral glucose tolerance tests were not conducted in the NHESIII, preventing an estimation of the exact prevalence of pre-diabetes. Long-term glycemic control could also not be assessed as A1C was not measured. Likewise, cholesterol fractions were not measured. Despite these limitations, a clear strength of the study is the large sample size and the ability to monitor diabetes prevalence and management at a subnational level.
This study demonstrates a high prevalence of diabetes and IFG across all regions of Thailand with low levels of diagnosis and appropriate management of blood glucose, blood pressure, and cholesterol among individuals with diabetes. These findings serve to emphasize to other countries undergoing similar epidemiological transitions the importance of establishing monitoring systems for diabetes built on valid and representative data. In Thailand, without increased efforts to prevent diabetes by promoting and facilitating healthier lifestyles along with improvements in the diagnosis and control of diabetes and associated risk factors, the health burden of diabetes has the potential to overwhelm the health care system. 
